Your browser doesn't support javascript.
loading
Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer.
Komatsu, Yoshito; Ishioka, Chikashi; Shimada, Ken; Yamada, Yasuhide; Gamoh, Makio; Sato, Atsushi; Yamaguchi, Tatsuro; Yuki, Satoshi; Morita, Satoshi; Takahashi, Shin; Goto, Rei; Kurihara, Minoru.
Afiliação
  • Komatsu Y; Department of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Kita-15 Nishi-7 Kita-ku, Sapporo, 060-8638, Japan. ykomatsu@ac.cyberhome.ne.jp.
  • Ishioka C; Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan. chikashi@idac.tohoku.ac.jp.
  • Shimada K; Department of Internal Medicine, Showa University Kouto Toyosu Hospital, 5-1-38 Toyosu, Kouto-ku, Tokyo, 135-8577, Japan. shimakenken60@hotmail.com.
  • Yamada Y; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. yayamada@ncc.go.jp.
  • Gamoh M; Department of Medical Oncology, Osaki Citizen Hospital, 2-3-10 Senjujicho, Hurukawa, Osaki Miyagi, 989-6183, Japan. m.gamoh-oc@h-osaki.jp.
  • Sato A; Department of Medical Oncology, Hirosaki University Graduate School of Medicine, 5 Zaifucho, Hirosaki, Aomori, 036-8562, Japan. sato1151@cc.hirosaki-u.ac.jp.
  • Yamaguchi T; Department of Surgery, Tokyo Metropolitan Cancer and Infectious diseases Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan. tatsuro@yamaguchi.email.ne.jp.
  • Yuki S; Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Kita-15 Nishi-7 Kita-ku, Sapporo, 060-8638, Japan. satoshi-yuuki175@joy.ocn.ne.jp.
  • Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. smorita@kuhp.kyoto-u.ac.jp.
  • Takahashi S; Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan. swt@idac.tohoku.ac.jp.
  • Goto R; Hakubi Center of Advanced Research, Kyoto University, Yoshida-Ushinomiyacho, Sakyo-ku, Kyoto, 606-8501, Japan. goto.rei.7w@kyoto-u.ac.jp.
  • Kurihara M; Graduate School of Economics, Kyoto University, Yoshida-Honmachi, Sakyo-ku, Kyoto, 606-8501, Japan. goto.rei.7w@kyoto-u.ac.jp.
BMC Cancer ; 15: 626, 2015 Sep 09.
Article em En | MEDLINE | ID: mdl-26353772
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Neoplasias Colorretais / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Aspecto: Patient_preference Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Neoplasias Colorretais / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Aspecto: Patient_preference Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Japão